The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries Training Course (Nov 12th - Nov 13th, 2025)" has been added to ...

Chitinases are specialised enzymes that catalyse the degradation of chitin, one of the most abundant natural polysaccharides. Found across diverse biological domains, these enzymes play crucial roles ...

Cyanophycin is a versatile nitrogen storage polymer naturally synthesised by many bacteria. Composed of a poly-L-aspartate backbone with covalently attached L-arginine residues, this biopolymer ...

PITTSBURGH, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization ...

PRINCETON, N.J., Sept. 13, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or Company), a clinical-stage immunotherapy company developing a growing pipeline of ...

HANGZHOU, China--(BUSINESS WIRE)--Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell ...

GlaxoSmithKline (GSK) today announced the submission of a new drug application to the US Food and Drug Administration and new data from two Phase III trials for Rezonic TM /Zunrisa TM (casopitant), a ...

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical stage company developing telomere-targeting immunotherapies for cancer, today announced that the U.S. Food and Drug ...

FDA stated that it is not currently planning to hold an advisory committee meeting PITTSBURGH, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS), the leader ...

Legend Biotech Corporation LEGN, a global, clinical-stage biotechnology company developing and manufacturing novel therapies, announced today the submission of a New Drug Application (NDA) to the ...